Founded in 2003, Network Immunology Inc. is a privately held Vancouver-based preclinical stage biotechnology company focused on discovering and developing novel treatments for autoimmune conditions and infectious diseases. Network Immunology creates lasting value through pioneering research in the field of immunology which leads to new product concepts, product development, and finally to the acquisition/licensing of those products and associated intellectual property at early stages.


HEALTHTECH

View Details...